Cite
HARVARD Citation
Zhong, X. et al. (2021). Mitochondrial targeted doxorubicin derivatives delivered by ROS-responsive nanocarriers to breast tumor for overcoming of multidrug resistance. Pharmaceutical development and technology. pp. 21-29. [Online].